Study guide

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions

Key Takeaways Explain This Topic AI

Dynamic air removal (prevacuum) steam sterilization operates at 132°C to 135°C (270°F to 275°F) for a minimum of 4 minutes at 28 to 30 psi, whereas gravity displacement steam operates at 121°C (250°F) for 30 minutes at 15 psi.

Biological monitoring requires specific bacterial endospores: Geobacillus stearothermophilus for steam autoclaves and hydrogen peroxide gas plasma, and Bacillus atrophaeus for ethylene oxide (EtO) and dry heat.

Immediate-Use Steam Sterilization (IUSS) is strictly restricted to urgently needed, unwrapped individual instruments when no alternative sterile backup exists; it is strictly prohibited for implantable devices and never permitted for schedule convenience.

Toxic Anterior Segment Syndrome (TASS) is an acute, non-infectious anterior segment inflammatory toxic response occurring within 12 to 24 hours postoperatively, triggered by enzymatic detergent residues, glutaraldehyde residues, autoclave boiler amines, or heat-stable Gram-negative bacterial endotoxins.

The Bowie-Dick chemical indicator test evaluates mechanical air evacuation and detects vacuum leaks or air entrapment in dynamic air removal (prevacuum) autoclaves, and must be performed daily in an empty chamber on the first cycle.

Last updated: September 2026

Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions

Core Clinical Mandate: Intraocular ophthalmic surgery involves an immunologically privileged compartment that is exquisitely vulnerable to both microbial pathogens and sub-microscopic chemical toxins. The ophthalmic medical technologist must enforce absolute surgical asepsis, master the biophysics of steam and low-temperature gas sterilization, ensure rigorous biological spore monitoring, and eliminate chemical contaminants capable of precipitating blinding Toxic Anterior Segment Syndrome (TASS) or postoperative infectious endophthalmitis.

Environmental Controls & Surgical Aseptic Field Architecture

The ophthalmic surgical suite requires rigorous environmental engineering controls designed to prevent airborne particulates, microbial dispersion, and static electrical discharges.

Airflow Dynamics and Suite Microclimate

Positive Pressure Airflow: The operating room (OR) must maintain positive air pressure relative to surrounding hallways, sub-sterile corridors, and scrub sinks. When the surgical suite doors open, clean air flows outward, preventing contaminated corridor air from entering the operating room. A minimum differential pressure of +2.5 Pascals (0.01 inches of water column) is standard.

Air Exchange Rate: The heating, ventilation, and air conditioning (HVAC) system must deliver a minimum of 20 total air changes per hour (ACH) , with at least 4 of those air changes consisting of fresh outdoor air .

High-Efficiency Particulate Air (HEPA) Filtration: All incoming air must pass through terminal HEPA filters capable of capturing 99.97% of airborne particles ≥0.3 µm in diameter , effectively removing bacteria, fungi, and dust aerosols.

Temperature & Humidity Parameters:

Temperature: Maintained strictly between 20°C and 24°C (68°F to 75°F) . Temperatures above 24°C promote staff perspiration and bacterial shedding, while lower temperatures cause patient shivering, elevating systemic tremor and intraocular venous pressure.

Relative Humidity (RH): Maintained strictly between 20% and 60% (ideally 30% to 50%) . Relative humidity below 20% increases electrostatic discharge risk, desiccates mucous membranes, and impairs barrier drape adherence. Humidity above 60% impairs sterile packaging integrity and accelerates microbial replication on non-sterile surfaces.

Traffic Control & Spatial Zoning

Operating facilities are divided into three distinct operational zones to limit microbial bioburden:

Unrestricted Zone: Street clothes permitted (pre-op holding, reception, outer administrative areas).

Semi-Restricted Zone: Surgical scrub suits, dedicated OR footwear, and complete hair coverings (scrub caps/hoods) required (storage corridors, instrument processing rooms, sterile supply rooms).

Restricted Zone: Masks and protective eye coverings required wherever sterile fields are established or open surgical procedures are performed (operating rooms, laser procedure rooms).

Boundaries and Rules of the Sterile Field

Maintaining the sterile field demands continuous spatial awareness:

Draped Equipment and Furniture: Only the horizontal top surface of draped tables (Mayo stands, back tables) is considered sterile. Drapes hanging over the table edges are considered non-sterile.

Surgical Attire Sterile Boundaries: Sterile gowns are considered sterile in front from the mid-chest level down to the level of the sterile field or horizontal table height, and on the sleeves from 2 inches (5 cm) above the elbow down to the proximal edge of the stockinette cuff . The neckline, shoulders, armpits, and back of the gown are non-sterile.

Hands and Forearms: Gloved hands must remain above waist level and below eye level, resting either on the sterile field or clasped in front of the chest. Hands must never drop below the table level or cross into the axillary region.

Movement around the Field: Non-sterile personnel must maintain a minimum distance of 12 inches (30 cm) from any sterile surface, must face the sterile field when approaching, and must never reach across a sterile drape or basin.

Ophthalmic Surgical Antisepsis & Skin Preparation

Topical skin and conjunctival preparation in ophthalmic surgery requires unique agents due to the delicacy of ocular tissues:

Povidone-Iodine (Betadine) 5% vs. 10%:

5% Povidone-Iodine Solution: Instilled directly into the conjunctival sac, fornices, and onto the corneal surface for a minimum contact time of 2 to 3 minutes prior to draping. Povidone-iodine delivers free molecular iodine that rapidly penetrates bacterial cell walls, oxidizes cytoplasmic enzymes, and denatures proteins. It is the single most effective intervention proven to reduce conjunctival bacterial flora and prevent endophthalmitis in clinical trials (e.g., Endophthalmitis Vitrectomy Study).

10% Povidone-Iodine Solution: Applied in concentric outward circles to the periorbital skin, eyelids, brow, and cheek, extending from the orbital margin to the temporal hairline.

Chlorhexidine Gluconate (CHG) Contraindication: Chlorhexidine is strictly contraindicated for periocular or corneal antisepsis . Direct contact between chlorhexidine and corneal or conjunctival epithelium causes instantaneous, irreversible corneal endothelial toxicity , precipitating permanent corneal bullous keratopathy and requiring emergency corneal transplantation. Chlorhexidine is reserved strictly for skin antisepsis below the orbital rim or in patients with confirmed severe iodine anaphylaxis (in whom dilute sterile baby shampoo or 0.05% polyhexamethylene biguanide is used).

Steam Sterilization Modalities: Dynamic Air Removal vs. Gravity Displacement

Steam autoclaving remains the gold standard for thermal sterilization in healthcare facilities. Saturated steam kills microorganisms through latent heat transfer , inducing irreversible coagulation, cross-linking, and denaturation of structural proteins and vital cellular enzymes.

Operational Parameter Gravity Displacement Steam Autoclave Dynamic Air Removal (Prevacuum) Steam Autoclave

Mechanism of Air Evacuation Passive; steam enters top/sides and displaces cooler, denser air downward through gravity drain Active; mechanical vacuum pump or steam ejector pulses actively evacuate air before steam injection

  • Standard Temperature 121°C (250°F) 132°C to 135°C (270°F to 275°F)
  • Operating Chamber Pressure 15 psi (~103 kPa) 28 to 30 psi (~193 to 207 kPa)
  • Minimum Exposure Time (Wrapped) 30 minutes 4 minutes (minimum validated exposure)
  • Drying Cycle Duration 15 to 30 minutes 20 to 30 minutes (post-vacuum drying)

Penetration Dynamics Slower; vulnerable to air pockets inside narrow lumens and porous packages Rapid, uniform steam penetration into deep micro-lumens and complex hinged instruments

Air Removal Testing Required Not applicable (no mechanical vacuum) Mandatory Daily Bowie-Dick Test prior to processing

Primary Clinical Application Culture media, heat-stable liquids, non-porous flat instruments Complex ophthalmic instrument trays, phaco handpieces, lumened cannulas

The Physics of Latent Heat of Vaporization

When dry saturated steam contacts cooler instrument surfaces, it condenses into water droplets, releasing its latent heat of vaporization (~2,257 kJ/kg at atmospheric pressure; higher under pressure). This instantaneous release of thermal energy elevates instrument temperature to chamber ambient within seconds. If non-condensable room air remains trapped inside lumens or packages, it forms an insulating barrier that prevents saturated steam contact, drastically reducing heat transfer and leading to sterilization failure.

Immediate-Use Steam Sterilization (IUSS)

Immediate-Use Steam Sterilization (IUSS) —historically termed "flash sterilization"—refers to the rapid steam autoclaving of an unwrapped or single-layer contained instrument intended for immediate clinical use without storage.

Stringent Regulatory Restrictions (AAMI ST79, AORN, CDC):

Strict Emergency Indication Only: IUSS is permitted solely in urgent, unanticipated clinical events—such as when a unique, mission-critical microsurgical instrument (e.g., the only capsulorhexis forceps or specialized IOL inserter) is dropped during an ongoing surgical case and no sterile replacement exists.

Strictly Prohibited for Implants: IUSS must NEVER be used for implantable devices (e.g., intraocular lenses, capsular tension rings, glaucoma drainage devices, scleral buckles). Implants require a fully wrapped, verified terminal cycle with a biological indicator.

Prohibited for Convenience or Scheduling: Facilities must never use IUSS as a routine reprocessing protocol to compensate for inadequate instrument inventory or to accelerate room turnover.

Cycle Parameters: Typically conducted at 132°C to 135°C (270°F to 275°F) for 3 to 4 minutes in a dynamic air removal sterilizer, or 132°C for 10 minutes in a gravity displacement unit. Minimal or zero dry time is programmed.

Transfer Asepsis: The sterilized instrument must be transported immediately to the sterile field inside an FDA-cleared, rigid, sealed IUSS container with gasketed lids to prevent environmental contamination during transfer.

Loading diagram... Clinical Diagnostic Algorithm: Differentiating TASS vs. Infectious Endophthalmitis

Low-Temperature Sterilization Technologies: Gas Plasma vs. Ethylene Oxide

Thermolabile ophthalmic devices—such as fiberoptic light pipes, endoscopic cameras, vitrectomy drive cables, and diamond knife handles—cannot withstand the intense thermal stress of steam autoclaving. Low-temperature modalities provide effective microbicidal action below 55°C.

Hydrogen Peroxide Gas Plasma (Sterrad System)

Hydrogen peroxide gas plasma represents the predominant low-temperature sterilization modality in modern ambulatory surgical centers.

Physical Mechanism:

The chamber is evacuated to a deep vacuum (<0.5 Torr).

An aqueous solution of 59% to 95% hydrogen peroxide ( H 2 O 2 H_2O_2 H 2 ​ O 2 ​ ) is vaporized into the chamber, diffusing across all exposed instrument surfaces and penetrating lumens.

Radiofrequency (RF) electrical energy is applied to the chamber, exciting the vapor into a low-temperature gas plasma state.

The plasma reaction generates high-energy reactive free radicals—predominantly hydroxyl ( O H ∙ OH^\bullet O H ∙ ) and hydroperoxyl ( O O H ∙ OOH^\bullet OO H ∙ ) radicals —that violently disrupt cellular membrane phospholipids, cleave peptide backbones, and oxidize microbial DNA.

As RF energy decays, free radicals recombine into non-toxic, environmentally benign byproducts: water vapor ( H 2 O H_2O H 2 ​ O ) and gaseous oxygen ( O 2 O_2 O 2 ​ ) .

Operating Parameters: Cycle duration spans 28 to 55 minutes at temperatures between 45°C and 55°C (113°F to 131°F) .

Clinical Limitations & Requirements:

Zero Moisture Tolerance: Any residual water droplet on or inside an instrument vaporizes into the vacuum, causing the system to abort the sterilization cycle prematurely.

No Cellulose or Cotton: Paper, cotton, linen, and standard surgical drapes absorb hydrogen peroxide, inhibiting plasma generation. Instruments must be wrapped strictly in polypropylene wraps or sealed in Tyvek pouches .

Lumen Caliber Limits: Narrow, long-ended or blind-ended lumens restrict plasma penetration; processing must strictly comply with manufacturer-validated length-to-internal-diameter ratios.

Ethylene Oxide (EtO) Gas Sterilization

Ethylene oxide ( C 2 H 4 O C_2H_4O C 2 ​ H 4 ​ O ) is a cyclic ether that functions as a potent alkylating agent.

Mechanism: EtO replaces labile hydrogen atoms within sulfhydryl, amino, hydroxyl, and carboxyl groups of proteins and nucleic acids with a hydroxyethyl radical (alkylating DNA and RNA), causing total metabolic arrest and reproductive death.

Operating Parameters: Operates at 37°C to 55°C (99°F to 131°F) , relative humidity of 40% to 80% , and gas concentration of 450 to 1,200 mg/L over an exposure duration of 1 to 6 hours .

Severe Clinical Hazards & Aeration Mandate:

Systemic Toxicity: EtO is an OSHA-regulated human carcinogen, mutagen, and reproductive toxin.

Ocular Chemical Necrosis: EtO dissolves readily in plastics, silicone, and elastomeric tubing. If residual EtO reacts with moisture, it generates ethylene glycol (antifreeze) and ethylene chlorohydrin , both of which induce severe corneal endothelial necrosis, intractable uveitis, and corneal melting.

Mandatory Aeration Cycle: Instruments processed in EtO must undergo prolonged, heated aeration in a dedicated mechanical aerator for 8 to 12 hours at 50°C to 60°C , or ambient aeration for a minimum of 7 days (168 hours) before safe clinical use. Consequently, EtO is rarely used for rapid instrument turnaround in ophthalmic centers.

Sterilization Monitoring & Indicators: Chemical vs. Biological Systems

Sterilization assurance requires systematic verification across three complementary tiers: physical monitors, chemical indicators, and biological indicators.

Physical Monitors

Microprocessor printouts and digital displays monitor and record physical chamber parameters in real time throughout each cycle: time, temperature, chamber pressure, and vacuum levels . Technologists must inspect and sign each cycle printout before releasing sterilized loads.

Chemical Indicators (ANSI/AAMI/ISO 11140-1 Classification)

Chemical indicators utilize heat-sensitive chemical inks that undergo a visible, irreversible color transition when exposed to specific physical parameters.

Indicator Class Category Name Function & Performance Standard Primary Clinical Use

Class 1 Process Indicators External tape or pack stripes; reacts to a single parameter (heat) to differentiate processed from unprocessed packages External package labels, autoclave tape

Class 2 Specific Test Indicators Evaluates specific operational equipment functions; exemplifies the Bowie-Dick Test Daily vacuum leak and air removal testing in prevacuum sterilizers

Class 3 Single-Variable Indicators Designed to react to one critical parameter (e.g., temperature threshold only) Specialized single-parameter validation

Class 4 Multi-Variable Indicators Reacts to two or more critical parameters (e.g., time AND temperature) Internal pouch and wrap monitoring

Class 5 Integrating Indicators Reacts to ALL critical sterilization variables (time, temperature, saturated steam) over a performance range correlating to biological kill curves Internal tray release; required inside every surgical cassette

Class 6 Emulating Indicators Cycle verification indicators; calibrated to specific cycle parameters (e.g., 134°C for 4.0 minutes) Precise verification of dedicated cycle regimes

The Bowie-Dick Test for Dynamic Air Removal Sterilizers

The Bowie-Dick test is an ANSI/AAMI Class 2 chemical indicator test designed exclusively for dynamic air removal (prevacuum) autoclaves :

Operational Standard: Conducted every operating day on the first cycle of the morning , in an otherwise completely empty chamber .

Mechanism: A standardized porous test pack (consisting of uniform cotton towels or specialized disposable porous paper sheets) containing a central cross-hatched chemical indicator sheet is placed horizontally over the bottom drain of the autoclave.

Diagnostic Interpretation: A successful test produces a completely uniform, homogeneous color change (e.g., yellow to dark black) across every square millimeter of the sheet. If a vacuum pump defect, gasket leak, or steam valve failure leaves an air pocket trapped within the pack, the center of the sheet remains unchanged or shows mottled, blotchy discoloration. Any non-uniform result requires immediate machine shutdown, quarantine, and biomedical engineering service.

Biological Indicators (BIs): The Ultimate Microbiological Verification

Biological indicators represent the only direct, unequivocal proof of complete microbial lethality. BIs utilize standardized vials containing > 10 6 >10^6 > 1 0 6 viable endospores of known resistance, suspended alongside a growth culture medium and pH indicator dye. Biological Indicator Validation Protocol:

  • [Autoclave Cycle Completed with BI Vial Inside Challenge Pack]
  • │
  • ▼
  • [Crush Internal Glass Ampoule -> Spores Mix with Nutrient Broth]
  • │
  • ▼
  • [Incubate Processed BI Vial + Non-Sterilized Positive Control Vial]
  • │
  • ▼
  • ┌─────────────────┴─────────────────┐
  • ▼ ▼
  • [Test Vial Remains Purple/Clear] [Test Vial Turns Yellow / Turbid]
  • (No Bacterial Growth = PASSED) (Bacterial Acid Growth = FAILED!)
  • Load Cleared for Clinical Use RECALL ENTIRE LOAD + Quarantine Autoclave

Spore Selection by Modality:

Steam Autoclaves & Hydrogen Peroxide Gas Plasma: Geobacillus stearothermophilus (formerly Bacillus stearothermophilus ). This thermophilic, spore-forming Gram-positive bacterium produces spores exhibiting supreme thermal resistance. Incubation is conducted at 55°C to 60°C ; rapid readout fluorescence systems detect enzymatic activity within 20 minutes to 3 hours , while standard visual acid growth checks require 24 to 48 hours.

Ethylene Oxide & Dry Heat Sterilizers: Bacillus atrophaeus (formerly Bacillus subtilis var. niger ). This mesophilic organism exhibits superior resistance to chemical alkylation. Incubation is conducted at 35°C to 37°C for 24 to 48 hours .

Testing Frequency: Biological monitoring must be performed at least weekly , preferably daily , and is mandatory for every single load containing an implantable device (with quarantine until the BI result is finalized negative).

Toxic Anterior Segment Syndrome (TASS) vs. Infectious Endophthalmitis

Toxic Anterior Segment Syndrome (TASS) is an acute, non-infectious, sterile inflammatory reaction of the anterior chamber triggered by intraoperative entry of a chemical or particulate toxin. It represents one of the most critical clinical emergencies encountered in ophthalmic surgical centers.

Etiologic Agents and Pathophysiology of TASS

Unlike infectious endophthalmitis—which involves microbial replication—TASS is entirely abacterial and abiotic. The offending toxins directly injure corneal endothelial cells, the trabecular meshwork, and the iris sphincter/dilator complex:

Enzymatic Detergent Residues: Ultrasonic cleaning solutions utilize proteolytic enzymatic detergents. If micro-cannulas, phaco needles, or I/A handpieces are not flushed with vast volumes of critical water, dried detergent proteins remain inside lumens. During subsequent surgery, irrigation drives these active alkaline enzymes directly into the anterior chamber, inducing massive corneal endothelial cell lysis.

Glutaraldehyde (Cidex) Residues: Glutaraldehyde is a potent chemical sterilant/disinfectant. It binds irreversibly to surgical instrument metals and cannot be reliably rinsed out of micro-lumens. Glutaraldehyde is exquisitely cytotoxic to corneal endothelial cells. Glutaraldehyde is strictly contraindicated for intraocular ophthalmic instruments.

Heat-Stable Bacterial Endotoxins (Lipopolysaccharides - LPS): Gram-negative bacteria living in municipal tap water, deionizer filtration beds, or contaminated ultrasonic baths produce outer membrane lipopolysaccharides. While autoclaving at 134°C readily kills live bacteria, endotoxins are heat-stable and withstand standard steam sterilization intact. When endotoxin-contaminated cannulas enter the anterior chamber, endotoxins bind toll-like receptors (TLR4), triggering a massive sterile leukocytic storm.

Autoclave Boiler Additives & Neutralizing Amines: Hospital steam lines frequently inject volatile boiler corrosion inhibitors—such as cyclohexylamine, diethylaminoethanol, and morpholine —to protect municipal piping from acidic condensate. These neutralizing amines carry over into the autoclave chamber steam and deposit as toxic films on microsurgical instruments. Facilities processing intraocular instruments must employ dedicated clean steam generators operating on additive-free, deionized steam.

Intracameral Drug & Preservative Toxicity: Inadvertent intraocular injection of preserved medications containing benzalkonium chloride (BAK) , stabilized epinephrine containing sodium bisulfite, or hypertonic/hypotonic solutions disrupts endothelial cell gap junctions, causing instantaneous permanent corneal opacification.

Comprehensive Differential Diagnosis: TASS vs. Infectious Endophthalmitis

Clinical Parameter Toxic Anterior Segment Syndrome (TASS) Postoperative Infectious Endophthalmitis

Clinical Onset Acute: 12 to 24 hours postoperatively Delayed: 3 to 7 days post-op (acute bacterial) or weeks (fungal/ C. acnes )

Patient Pain Level Painless or disproportionately mild discomfort despite severe inflammation Severe, agonizing, deep ocular pain ; worsening throbbing ache

Corneal Manifestation Diffuse, limbus-to-limbus corneal edema ; "ground-glass" corneal stroma Cornea typically clear initially; localized edema restricted to surgical wound

Anterior Chamber Reaction Intense fibrin membrane, 3+ to 4+ cell/flare, sterile layered hypopyon Fibrin clot, cellular reaction, progressive exudative hypopyon

Pupillary Dynamics Fixed, dilated, or irregular pupil (iris sphincter necrosis / neuroparalysis) Sluggish or normal pupillary response; rarely dilated

Intraocular Pressure (IOP) High early IOP spikes common (trabecular endothelial toxicity/edema) Variable (normal, low from ciliary shutdown, or high)

Posterior Segment / Vitreous Vitreal clarity preserved ; no vitritis; normal fundus view and clear B-scan Dense vitritis , vitreal cellular debris, lost red reflex, vitreous abscesses

Etiology Chemical toxins, detergent residues, boiler amines, endotoxins Viable proliferating pathogens ( Staph. epidermidis , Staph. aureus , Pseudomonas )

Definitive Treatment Intensive topical corticosteroids (prednisolone 1% q1h) + topical cycloplegics Emergent vitreous tap/biopsy + intravitreal antibiotics (Vancomycin + Ceftazidime)

Clinical Trajectory Rapid, dramatic improvement within 24 to 48 hours of steroid initiation Rapidly worsens if untreated; permanent blindness within 24–48 hours

Surgical site identification and the time out

Surgical site identification is a named task in the surgical assisting content area at every certification level, and it is the one surgical duty where a technologist's error is unrecoverable. Wrong-eye surgery and wrong-power intraocular lens implantation are classified as never events: they are considered wholly preventable, and they are reportable.

The Universal Protocol has three parts, and the technologist has a role in each.

Pre-procedure verification. Before the patient is sedated, confirm that the operative eye stated by the patient matches the consent form, the surgeon's booking, the history and the biometry printout. The patient states the eye; you do not lead them by asking "it's the right eye today, isn't it?" Any mismatch stops the process until the surgeon resolves it — a technologist who notices a discrepancy and stays quiet has participated in the error.

Marking the site. The operative eye is marked before the patient enters the room and before sedation, by the person performing the procedure, with the patient involved and awake wherever possible. The mark must remain visible after skin preparation and draping, which is why a brow or temple mark is used rather than a mark that the drape will cover.

The time out. Immediately before the incision, the whole team stops and verbally confirms the patient's identity, the procedure, and the operative eye. In cataract surgery the time out also confirms the intraocular lens model and power read aloud against the biometry and the surgeon's plan, because a correct eye with the wrong lens is still a wrong-site-class event.

Two ophthalmic details recur in examination items. First, dilating drops are themselves a laterality decision: instilling them in the wrong eye starts a chain of errors that the drape then hides, so confirm the eye before the first drop, not just before the incision. Second, the marked eye must be verified against the patient and the consent , never against the position of the chart on the worklist or the order in which cases were booked.